Young-Seok Seo
Fortuna: 916 530 $ al 31/07/2026
Fortuna: 916 530 $ al 31/07/2026
Young-Seok Seo currently works at IntoCell, Inc., as CFO, Director & Head-Business Management from 2020 and Daeju Accounting Corp., as Accountant.
Mr. Seo also formerly worked at JC Chemical Co., Ltd., as Auditor.
Mr. Seo received his undergraduate degree in 1981 from Pusan National University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
INTOCELL, INC. 0,54 % | 02/02/2026 | 80.760 ( 0,54 % ) | 916 530 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INTOCELL, INC. | Director Financiero/CFO | 01/06/2019 |
Grant Thornton Daejoo LLC
Grant Thornton Daejoo LLC Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | 16/08/2011 |
| Empresas | Cargo | Fin |
|---|---|---|
| JC CHEMICAL CO., LTD. | Comptroller/Controller/Auditor | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Pusan National University
Pusan National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JC Chemical Co., Ltd.
JC Chemical Co., Ltd. Chemicals: SpecialtyProcess Industries Manufactures and sells biodiesel | Process Industries |
Grant Thornton Daejoo LLC
Grant Thornton Daejoo LLC Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
IntoCell, Inc.
IntoCell, Inc. BiotechnologyHealth Technology Engages in research and development of protein & antibody drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.